APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 16 filers reported holding APTOSE BIOSCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $290 | – | 500 | +49900.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | -99.5% | 0.00% | – |
| Q1 2022 | $0 | – | 200 | +212.5% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 64 | -99.7% | 0.00% | – |
| Q1 2021 | $149,000 | +14800.0% | 24,976 | +10011.7% | 0.00% | – |
| Q4 2020 | $1,000 | -99.6% | 247 | -99.5% | 0.00% | – |
| Q3 2020 | $281,000 | +360.7% | 46,886 | +383.9% | 0.00% | – |
| Q2 2020 | $61,000 | – | 9,690 | +5600.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 170 | -83.0% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 1,000 | +100.0% | 0.00% | – |
| Q3 2018 | $1,000 | -94.1% | 500 | -88.4% | 0.00% | – |
| Q2 2018 | $17,000 | +750.0% | 4,300 | +760.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 500 | +66.7% | 0.00% | – |
| Q3 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 300 | -93.8% | 0.00% | – |
| Q4 2016 | $7,000 | -50.0% | 4,800 | -20.0% | 0.00% | – |
| Q3 2016 | $14,000 | +366.7% | 6,000 | +500.0% | 0.00% | – |
| Q1 2016 | $3,000 | -25.0% | 1,000 | +42.9% | 0.00% | – |
| Q1 2015 | $4,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
| SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
| Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
| PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
| DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
| Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
| CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
| Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
| Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
| WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |